Association between sodium content of intravenous immunoglobulin and electrolyte changes and clinical course of Kawasaki disease
Clinical and Experimental Pediatrics · 15.08.2026 · 69 (8) · 639-645
DOI: 10.3345/cep.2026.00619 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Pediatrics, erschienen am 15.08.2026. Verfasst von Yoshitaka Watanabe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Children's Medical Center, Showa Medical University, Northern Yokohama Hospital, Yokohama, Japan. Die Arbeit nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Background
Intravenous immunoglobulin (IVIG) formulations used to treat Kawasaki disease differ markedly in sodium content; however, the clinical significance of this factor remains unclear.
Purpose
Here we investigated whether sodium content influences electrolyte changes and short-term clinical outcomes of Kawasaki disease.
Methods
This single-center retrospective cohort study included 744 children with first-episode Kawasaki disease treated with 2-kg IVIG in 2010–2020. The patients were categorized into high-sodium (Glovenin-I or Venilon-I) and low-sodium (Venoglobulin IH) groups. Serum electrolytes, total protein, and immunoglobulin G levels were measured before and after IVIG administration. Outcomes included additional IVIG administration and the presence of coronary artery lesions.
Results
Compared to the low-sodium group, the high-sodium group had significantly increased serum sodium (2.9±3.2 mEq/L vs. 1.7±2.7 mEq/L) but significantly decreased serum potassium (-0.13±0.50 mEq/L vs. -0.03±0.49 mEq/L) levels after IVIG therapy. After its administration, hyponatremia occurred more often in the low-sodium group (4.4% vs. 0.3%), whereas hypokalemia occurred more frequently in the high-sodium group (9.9% vs. 5.5%). Total protein, immunoglobulin G, and albumin levels were higher in the low-sodium group. The rates of additional IVIG use and coronary artery lesions did not differ significantly between groups.
Conclusion
Our findings demonstrate that the sodium content of IVIG contributes to distinct changes in electrolyte and protein concentrations during the acute phase of Kawasaki disease. However, these biochemical differences were not associated with short-term clinical outcomes. Awareness of formulation-specific profiles may help clinicians interpret laboratory findings appropriately during IVIG therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Children's Medical Center, Showa Medical University, Northern Yokohama Hospital, Yokohama, Japan.
- Children's Medical Center, Showa Medical University, Northern Yokohama Hospital, Yokohama, Japan. ihirokazu@med.showa-u.ac.jp.
Zitieren
APA
Watanabe, Y., Yagi, N., Hattori, T., Oyake, C., Endo, S., Yoshimi, M., Kyoda, T., & Ikeda, H. (2026). Association between sodium content of intravenous immunoglobulin and electrolyte changes and clinical course of Kawasaki disease. Clinical and Experimental Pediatrics, 69(8), 639-645. https://doi.org/10.3345/cep.2026.00619
Vancouver
Watanabe Y, Yagi N, Hattori T, Oyake C, Endo S, Yoshimi M, et al. Association between sodium content of intravenous immunoglobulin and electrolyte changes and clinical course of Kawasaki disease. Clinical and Experimental Pediatrics. 2026;69(8):639-645. doi:10.3345/cep.2026.00619
BibTeX
@article{Watanabe2026,
author = {Watanabe, Yoshitaka and Yagi, Naomi and Hattori, Toya and Oyake, Chisato and Endo, Shota and Yoshimi, Maria and Kyoda, Takayoshi and Ikeda, Hirokazu},
title = {Association between sodium content of intravenous immunoglobulin and electrolyte changes and clinical course of Kawasaki disease},
journal = {Clinical and Experimental Pediatrics},
year = {2026},
volume = {69},
number = {8},
pages = {639--645},
doi = {10.3345/cep.2026.00619}
}
EUVIMED